Meet Our Team

Proven Pharmaceutical and Ophthalmic Execution

Leadership Team

Dan Myers
Chief Executive Officer

Dan Myers was appointed as Chief Executive Officer of MediPrint™ Ophthalmics in 2020. Prior to joining MediPrint Ophthalmics, Dan Myers was the co-founder and Chief Executive Officer of Alimera Sciences, where he continues to serve as chairman of the Board of Directors. Before founding Alimera, Mr. Myers was a founding employee of Novartis Ophthalmics (formerly CIBA Vision Ophthalmics) and served as its President from 1997 to 2003. Mr. Myers has over 35 years of ophthalmic pharmaceutical experience, including over 21 years in the role of president or chief executive officer.

Praful Doshi
Founder, Chief Technology Officer

Mr. Doshi has over 40 years of experience working at major contact lens companies including Pilkington Barnes Hind, Wesley Jessen, and Bausch+Lomb. His creative vision and innovative approach to solving the problems faced by contact lens manufacturers, eye care professionals, and contact lens users has resulted in 40+ patents. He is recognized as a leader in the field of drug delivery from contact lenses, for his entrepreneurial spirit, and for his passion for helping to protect sight.

Kenny Key, J.D.
Chief Operating Officer, General Counsel
David Fancher
Business Development
Orlando Rodrigues
Commercial

Board of Directors

Praful Doshi
Chairman
Dan Myers
Board Member
Kokila Doshi
Board Member
Houman Hemmati, MD, PhD
Board Member

Scientific Advisory Board

Robert Davis, OD, FAAO
Clinical Advisor
Mark Dunbar, OD, FAAO
Clinical Advisor
Ian Benjamin Gaddie, OD, FAAO
Clinical Advisor
Jo Ann Giaconi, MD
Clinical Advisor
Houman Hemmati, MD, PhD
Clinical Advisor
Constance Okeke, MD, MSCE
Clinical Advisor
Walter Whitley, OD, MBA, FAAO
Clinical Advisor